Tetrahydroquinoline/4,5‐Dihydroisoxazole Molecular Hybrids as Inhibitors of Breast Cancer Resistance Protein (BCRP/ABCG2)
Open Access
- 12 April 2021
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 16 (17) , 2686-2694
Abstract
Multidrug resistance (MDR) is one of the major factors in the failure of many chemotherapy approaches. In cancer cells, MDR is mainly associated with the expression of ABC transporters such as P‐glycoprotein, MRP1 and ABCG2. Despite major efforts to develop new selective and potent inhibitors of ABC drug transporters, no ABCG2‐specific inhibitors for clinical use are yet available. Here, we report the evaluation of sixteen tetrahydroquinoline/4,5‐dihydroisoxazole derivatives as a new class of ABCG2 inhibitors. The affinity of the five best inhibitors was further investigated by the vanadate‐sensitive ATPase assay. Molecular modelling data, proposing a potential binding mode, suggest that they can inhibit the ABCG2 activity by binding on site S1, previously reported as inhibitors binding region, as well targeting site S2, a selective region for substrates, and by specifically interacting with residues Asn436, Gln398, and Leu555. Altogether, this study provided new insights into THQ/4,5‐dihydroisoxazole molecular hybrids, generating great potential for the development of novel most potent ABCG2 inhibitors.Keywords
Funding Information
- Opetushallitus (400953/2016-1)
- National Cancer Institute
This publication has 61 references indexed in Scilit:
- Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2European Journal of Medicinal Chemistry, 2013
- Investigation of Chalcones as Selective Inhibitors of the Breast Cancer Resistance Protein: Critical Role of Methoxylation in both Inhibition Potency and CytotoxicityJournal of Medicinal Chemistry, 2012
- Identification of Proline Residues in or near the Transmembrane Helices of the Human Breast Cancer Resistance Protein (BCRP/ABCG2) That Are Important for Transport Activity and Substrate SpecificityBiochemistry, 2011
- Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand BindingJournal of the American Chemical Society, 2008
- Modulation of the function of the multidrug resistance–linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcuminMolecular Cancer Therapeutics, 2006
- The nature of amino acid 482 of human ABCG2 affects substrate transport and ATP hydrolysis but not substrate bindingProtein Science, 2006
- OPM: Orientations of Proteins in Membranes databaseBioinformatics, 2006
- Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking AccuracyJournal of Medicinal Chemistry, 2004
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983